Health Condition 1: L405- Arthropathic psoriasis
Conditions
Interventions
Intervention1: Individualized Homoeopathic Medicines: The individualized homoeopathic medicine with potency starting from 6C to 50M will be given orally, in 4 to 6 pills of number 30 size. The frequen
Sponsors
Dr Anusree P B
Eligibility
Inclusion criteria
Inclusion criteria: Patients in the age group of 18-65 years and of both genders. Patients who fulfil the CASPAR criteria.
Exclusion criteria
Exclusion criteria: Patients with known conditions such as gout, osteoarthritis, rheumatoid arthritis, etc., Patients having known severe structural deformity. Pregnant and lactating women. Patients with known advanced systemic illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in DAPSA score baseline, 3 rd, 6th, 9th and 12th month for interpreting the disease activity in psoriatic arthritis.Timepoint: Baseline, 3rd, 6th, 9th and 12th month. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the severity of skin lesions in psoriasis using PASI - baseline, 3rd, 6th, 9th & 12th month Evaluation of disability using HAQ – DI baseline, 6th month & 12th monthTimepoint: PASI baseline, 3rd, 6th, 9th & 12th month HAQ - DI baseline, 6th month & 12th month | — |
Countries
India
Contacts
Public ContactDr P Dastagiri
National Homoeopathy Research Institute in Mental Health, Kottayam
Outcome results
None listed